Positive thyroid transcription factor 1 staining strongly correlates with survival of patients with adenocarcinoma of the lung
2005

TTF1 Staining and Lung Cancer Survival

Sample size: 106 publication Evidence: high

Author Information

Author(s): Barlési F, Pinot D, LeGoffic A, Doddoli C, Chetaille B, Torre J-P, Astoul P

Primary Institution: Faculty of Medicine – Assistance Publique Hôpitaux de Marseille

Hypothesis

Does positive thyroid transcription factor 1 (TTF1) staining correlate with survival in patients with adenocarcinoma of the lung?

Conclusion

Positive TTF1 staining strongly and independently correlates with survival of patients with primary adenocarcinoma of the lung.

Supporting Evidence

  • Positive TTF1 staining was found in 66% of tumors.
  • Patients with positive TTF1 staining had a lower risk of death (HR=0.40).
  • The study included 106 patients diagnosed with adenocarcinoma from 2002 to 2004.

Takeaway

If a lung cancer patient has a positive TTF1 test, they are likely to live longer than those who do not.

Methodology

The study analyzed pathological tissue from consecutive adenocarcinoma patients, assessing TTF1 staining and correlating it with survival using Kaplan-Meier and Cox regression analyses.

Potential Biases

Potential bias in patient selection and the retrospective nature of the study.

Limitations

The study only included patients with adenocarcinoma and may not generalize to other types of lung cancer.

Participant Demographics

66% male, 69% with performance status 0-1, 83% with stage III or IV disease.

Statistical Information

P-Value

P<0.0001

Confidence Interval

95% CI 0.25–0.65

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1038/sj.bjc.6602717

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication